Molecular Docking and Dynamic Simulation of Erythrina fusca Lour Chemical Compounds Targeting VEGFR-2 Receptor for Anti-Liver Cancer Activity
Abstract
Liver cancer is a serious health concern characterized by abnormal cell growth, but currently, available treatment options are limited, suggesting the need for a new therapeutic method. Therefore, this research aimed to investigate the potential of chemical compounds obtained from the cangkring plant (Erythrina fusca) as anti-liver cancer agents targeting Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2). The investigation was conducted in silico through molecular docking and dynamic method. Molecular docking was performed using AutoDock Tools, followed by visualization with Biovia Discovery Studio. Additionally, molecular dynamics simulation was conducted using GROMACS software and visualized with Grace. A total of 36 chemical compounds from E. fusca were used as ligands for molecular docking. The results showed that Isobavachalcone (ISB) was the most effective test compound with a binding energy of -11.45 kcal/mol, compared to the positive control Sorafenib with a value of - 11.51 kcal/mol. In this context, hydrogen bonding, as well as hydrophobic, electrostatic, and unfavorable molecular interactions were identified. Moreover, molecular dynamics simulation provided RMSD, RMSF, Radius of Gyration (Rg), and hydrogen bond parameters. Analysis of these parameters further confirmed the superior stability of ISB in binding to VEGFR-2, suggesting the potential to suppress angiogenesis by blocking the receptor.
Keywords
References
Liu, C. Y., Chen, K. F. & Chen, P. J. Treatment of liver cancer. Cold Spring Harb Perspect Med 5, (2015).
Rumgay, H. et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol 77, 1598–1606 (2022).
Mutiah, R., Fawwaz Hariz, M., Yen, Y., Indrawijaya, A. & Ma’arif, B. In Silico Prediction of Isoliquiritigenin and Oxyresveratrol Compounds to BCL-2 dan VEGF-2 Receptors. Indonesian Journal of Cancer Chemoprevention (2019).
Cervello, M. et al. Molecular mechanisms of sorafenib action in liver cancer cells. Cell Cycle 11, 2843–2855 (2012).
Chen, C. & Wang, G. Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy. World Journal of Hepatology vol. 7 1964–1970 Preprint at https://doi.org/10.4254/wjh.v7.i15.1964 (2015).
Eweas, A. F., Khalifa, N. M., Ismail, N. S., Al-Omar, M. A. & Soliman, A. M. M. Synthesis, molecular docking of novel 1,8-naphthyridine derivatives and their cytotoxic activity against HepG2 cell lines. Medicinal Chemistry Research 23, 76–86 (2014).
Nascimento, I. J. dos S., de Aquino, T. M. & da Silva-Júnior, E. F. The New Era of Drug Discovery: The Power of Computer-aided Drug Design (CADD) . Lett Drug Des Discov 19, 951–955 (2022).
Pinzi, L. & Rastelli, G. Molecular docking: Shifting paradigms in drug discovery. International Journal of Molecular Sciences vol. 20 Preprint at https://doi.org/10.3390/ijms20184331 (2019).
Ferreira, L. G., Dos Santos, R. N., Oliva, G. & Andricopulo, A. D. Molecular docking and structure-based drug design strategies. Molecules vol. 20 13384–13421 Preprint at https://doi.org/10.3390/molecules200713384 (2015).
Haffez, H. et al. Novel N-Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulations. J Enzyme Inhib Med Chem 38, (2023).
Anjum, A. et al. Flavonoid, pterocarpans and steroid from Erythrina fusca Lour. growing in Bangladesh: Isolation, and antimicrobial and free-radical scavenging activity. Journal of Medicinal Plants 20, 37–46 (2021).
Chagas, C. M., Moss, S. & Alisaraie, L. Drug metabolites and their effects on the development of adverse reactions: Revisiting Lipinski’s Rule of Five. International Journal of Pharmaceutics vol. 549 133–149 Preprint at https://doi.org/10.1016/j.ijpharm.2018.07.046 (2018).
Rachmania, R. A. S. and O. A. Larasati. Analisis In-Silico Senyawa Diterpenoid Lakton Herba Sambiloto (Andrographis paniculata Nees) pada Reseptor Alpha-Glucosidase sebagai Antidiabetes Tipe II. Pharmacy: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia) 12, 210–222 (2015).
Rena, S. R., Nurhidayah, N. & Rustan, R. Analisis Molecular Docking Senyawa Garcinia Mangostana L Sebagai Kandidat Anti SARS-CoV-2. Jurnal Fisika Unand 11, 82–88 (2022).
Fakih, T. M., Jannati, F. A., Meilani, A., Ramadhan, D. S. F. & Darusman, F. Studi In Silico Aktivitas Analog Senyawa Zizyphine dari Bidara Arab (Zizyphus spina-christi) sebagai Antivirus SARS-CoV-2 terhadap Reseptor 3CLpro. ALCHEMY Jurnal Penelitian Kimia 18, 70 (2022).
Kurnyawaty, N., Suwito, H. & Kusumattaqiin, F. Studi In Silico Potensi Aktivitas Farmakologi Senyawa Golongan Dihidrotetrazolopirimidin. Jurnal Kimia 172 (2021) doi:10.24843/jchem.2021.v15.i02.p07.
Cyntia Wibowo, M., Catherina Widjajakusuma, E. & Ervina, M. Studi Pendahuluan Penambatan Molekul Senyawa Kandungan Dari Cinnamomi Cortex terhadap Epitop Respiratory Syncytial Virus (RSV). (2022).
Sari, I. W., Junaidin, J. & Pratiwi, D. Studi Molecular Docking Senyawa Flavonoid Herba Kumis Kucing (Orthosiphon stamineus B.) Pada Reseptor α-Glukosidase Sebagai Antidiabetes Tipe 2. Jurnal Farmagazine 7, 54 (2020).
Frimayanti, N. et al. Studi molecular docking senyawa 1,5-benzothiazepine sebagai inhibitor dengue DEN-2 NS2B/NS3 serine protease. Chempublish Journal 6, 54–62 (2021).
Varma, A. K. et al. Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of Drug-Designing. PLoS One 5, (2010).
Lemkul, J. From Proteins to Perturbed Hamiltonians: A Suite of Tutorials for the GROMACS-2018 Molecular Simulation Package [Article v1.0]. Living J Comput Mol Sci 1, (2019).
Hassan, M. et al. Molecular docking and dynamic simulation of AZD3293 and solanezumab effects against BACE1 to treat alzheimer’s disease. Front Comput Neurosci 12, (2018).
Lee, J. et al. CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field. J Chem Theory Comput 12, 405–413 (2016).
Gerrard, J. A. & Domigan, L. J. Protein Nanotechnology. (Springer Science+Business Media, LLC, Auckland, New Zealand, 2020). doi:https://doi.org/10.1007/978-1-4939-9869-2.
Ali, A., Le, T. T. B., Striolo, A. & Cole, D. R. Salt Effects on the Structure and Dynamics of Interfacial Water on Calcite Probed by Equilibrium Molecular Dynamics Simulations. Journal of Physical Chemistry C 124, 24822–24836 (2020).
Ke, Q., Gong, X., Liao, S., Duan, C. & Li, L. Effects of thermostats/barostats on physical properties of liquids by molecular dynamics simulations. J Mol Liq 365, (2022).
Sneha, P. & Priya Doss, C. G. Molecular Dynamics: New Frontier in Personalized Medicine. in Advances in Protein Chemistry and Structural Biology vol. 102 181–224 (Academic Press Inc., 2016).
Zubair, M. S., Maulana, S. & Mukaddas, A. Penambatan Molekuler dan Simulasi Dinamika Molekuler Senyawa Dari Genus Nigella Terhadap Penghambatan Aktivitas Enzim Protease HIV-1. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) 6, 132–140 (2020).
Zein Muttaqin, F., Ismail, H. & Nasrullah Muhammad, H. Studi Molecular Docking, Molecular Dynamic, Dan Prediksi Toksisitas Senyawa Turunan Alkaloid Naftiridin Sebagai Inhibitor Protein Kasein Kinase 2-α Pada Kanker Leukemia. Pharmacoscript 2, 49–64 (2019).
Supandi, Yeni & Dwita, L. P. Docking studies and molecular dynamics simulation of compounds contained in kaempferia galanga l. To lipoxygenase (lox) for anti-inflammatory drugs. Journal of Mathematical and Fundamental Sciences 53, 218–230 (2021).
Rashid, H. ur et al. Molecular docking and dynamic simulations of Cefixime, Etoposide and Nebrodenside A against the pathogenic proteins of SARS-CoV-2. J Mol Struct 1247, (2021).
Frimayanti, N., Dona, R. & Cahyana, F. Simulasi Molecular Dynamic (MD) Senyawa Analog Kalkon Sebagai Inhibitor Untuk Sel Kanker Paru A549. Jurnal Penelitian Farmasi Indonesia 9, (2020).
DOI: 10.15408/jkv.v10i1.35295
Refbacks
Copyright (c) 2024 Dila Aulia Maharani, Rosa Adelina, Anggun Qurrota Aini, Supandi Supandi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
